These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20007959)

  • 1. Dendritic cells in chronic viral hepatitis B and C: victims or guardian angels?
    Woltman AM; Boonstra A; Janssen HL
    Gut; 2010 Jan; 59(1):115-25. PubMed ID: 20007959
    [No Abstract]   [Full Text] [Related]  

  • 2. Measuring immunity in viral hepatitis.
    Kanto T; Hayashi N
    J Gastroenterol; 2004 Aug; 39(8):709-16. PubMed ID: 15338363
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic infections with hepatotropic viruses: mechanisms of impairment of cellular immune responses.
    Rehermann B
    Semin Liver Dis; 2007 May; 27(2):152-60. PubMed ID: 17520515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical significance of cytokine level and T-cell lymphocyte response to B and C hepatic viral antigens in patients with type C and B+C hepatitis receiving antiviral therapy].
    Sobolevskaia OL; Korochkina OV
    Klin Med (Mosk); 2007; 85(7):63-6. PubMed ID: 17882815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Autoimmune lesions of thyroid as complications of interferon treatment of chronic viral hepatitis].
    Ettinger OA; Nikitin IG; Storozhakov GI
    Ter Arkh; 1999; 71(12):69-72. PubMed ID: 10647210
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of oral immune regulation towards liver-extracted proteins for treatment of chronic HBV and HCV hepatitis: results of a phase I clinical trial.
    Israeli E; Safadi R; Melhem A; Pappo O; Shibolet O; Klein A; Hemed N; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Liver Int; 2004 Aug; 24(4):295-307. PubMed ID: 15287852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune responses in hepatitis C virus infection and mechanisms of hepatitis C virus persistence.
    Hiroishi K; Ito T; Imawari M
    J Gastroenterol Hepatol; 2008 Oct; 23(10):1473-82. PubMed ID: 18761560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
    Tsai SL; Lee TH; Chien RN; Liao SK; Lin CL; Kuo GC; Liaw YF
    J Immunol Methods; 2004 Feb; 285(1):71-87. PubMed ID: 14871536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GB virus type C-driven protection in HIV/HCV coinfection: possible role of interferon gamma and dendritic cell activation.
    Martini F; Sacchi A; Lalle E; Castilletti C; D'Offizi G; Abbate I; Capobianchi MR
    Gastroenterology; 2008 May; 134(5):1631-3; author reply 1633. PubMed ID: 18471541
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.
    Zheng BJ; Zhou J; Qu D; Siu KL; Lam TW; Lo HY; Lee SS; Wen YM
    J Viral Hepat; 2004 May; 11(3):217-24. PubMed ID: 15117323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between the dynamics of cytokines and the phenotypes of the disease in chronic HCV infection].
    Okumura A; Kakumu S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):164-9. PubMed ID: 15359786
    [No Abstract]   [Full Text] [Related]  

  • 12. [The role of dendritic cells in the infection by HIV and HCV].
    Belmonte L; Parodi C; Bare P; Baston M; Bracco MM; Ruibal-Ares B
    Medicina (B Aires); 2007; 67(1):63-70. PubMed ID: 17408026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients.
    Decalf J; Fernandes S; Longman R; Ahloulay M; Audat F; Lefrerre F; Rice CM; Pol S; Albert ML
    J Exp Med; 2007 Oct; 204(10):2423-37. PubMed ID: 17893202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recovery of functional cytotoxic T lymphocytes during lamivudine therapy by acquiring multi-specificity.
    Kondo Y; Asabe S; Kobayashi K; Shiina M; Niitsuma H; Ueno Y; Kobayashi T; Shimosegawa T
    J Med Virol; 2004 Nov; 74(3):425-33. PubMed ID: 15368520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic hepatitis C and B. What can be accomplished with antiviral therapy].
    MMW Fortschr Med; 2007 Feb; 149(7):14. PubMed ID: 17615650
    [No Abstract]   [Full Text] [Related]  

  • 16. Chronic viral hepatitis.
    Dakhil N; Junaidi O; Befeler AS
    Mo Med; 2009; 106(5):361-5. PubMed ID: 19902718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring patients with chronic hepatitis during and after therapy].
    Colić-Cvrlje V; Mise S
    Acta Med Croatica; 2009 Dec; 63(5):377-83. PubMed ID: 20198895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of chronic viral hepatitis].
    Pache I; Mondada D; Moradpour D; Fontana M
    Rev Med Suisse; 2007 Jan; 3(95):215, 217-8, 221-3. PubMed ID: 17357690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of anti-interferon-alpha2 and sICAM-1 activities in the sera of viral hepatitis B and C patients treated with human recombinant interferon-alpha2.
    Stancek D; Fuchsberger N; Oltman M; Schmeisser H; Kontsek P; Jahnová E; Hajnická V
    Acta Virol; 2001; 45(5-6):287-92. PubMed ID: 12083327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired ability of interferon-alpha-primed dendritic cells to stimulate Th1-type CD4 T-cell response in chronic hepatitis C virus infection.
    Miyatake H; Kanto T; Inoue M; Sakakibara M; Kaimori A; Yakushijin T; Itose I; Miyazaki M; Kuzushita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Viral Hepat; 2007 Jun; 14(6):404-12. PubMed ID: 17501761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.